NYSE:TEVA - Teva Pharmaceutical Industries Stock Price Target and Predictions

Target and Analyst Ratings
Price Target History
Upgrades and Downgrades
About
FAQ

Consensus Rating: Hold
Consensus Price Target: $11.25
Forecasted Upside: 11.28 %
Number of Analysts: 10
Breakdown:
1 Sell Ratings
7 Hold Ratings
2 Buy Ratings
0 Strong Buy Ratings

^$10.11 As of 06/21/2021 01:00 AM ET

▼ -0.01 (-0.10%)

1 month | 3 months | 12 months

Get New Teva Pharmaceutical Industries Analyst Ratings Delivered To Your Inbox

Sign-up to receive the latest news and ratings for TEVA and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for TEVA

^$11.25

▲ +11.28% Upside Potential

This price target is based on 10 analysts offering 12 month price targets for Teva Pharmaceutical Industries in the last 3 months. The average price target is $11.25, with a high forecast of $14.00 and a low forecast of $8.00. The average price target represents a 11.28% upside from the last price of $10.11.

Current Consensus is Hold

The current consensus among 10 contributing investment analysts is to hold stock in Teva Pharmaceutical Industries. This Hold consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details Read Past Recommendations Description Skip Past Price Target Consensus Chart

0 strong buy ratings
5 buy ratings
16 hold ratings
3 sell ratings

Ratings as of

12/29/2019

0 strong buy ratings
5 buy ratings
16 hold ratings
3 sell ratings

Ratings as of

3/28/2020

0 strong buy ratings
4 buy ratings
15 hold ratings
3 sell ratings

Ratings as of

6/26/2020

0 strong buy ratings
4 buy ratings
11 hold ratings
3 sell ratings

Ratings as of

9/24/2020

0 strong buy ratings
3 buy ratings
11 hold ratings
3 sell ratings

Ratings as of

12/23/2020

0 strong buy ratings
3 buy ratings
10 hold ratings
2 sell ratings

Ratings as of

3/23/2021

0 strong buy ratings
3 buy ratings
7 hold ratings
1 sell ratings

Ratings as of

5/22/2021

0 strong buy ratings
2 buy ratings
7 hold ratings
1 sell ratings

Ratings as of

6/21/2021

Latest Recommendations

Show Most Recent Rating from Each Ratings Firm Show All Ratings

Date	Brokerage	Action	Rating	Price Target	Impact on Share Price
5/10/2021	UBS Group	Reiterated Rating	Buy ➝ Neutral	$15.00 ➝ $11.00	N/A
5/4/2021	UBS Group	Downgrade	Buy ➝ Neutral	$15.00 ➝ $11.00	High
3/14/2021	JPMorgan Chase & Co.	Reiterated Rating	Hold	$10.00	Medium
12/28/2020	Raymond James	Reiterated Rating	Buy		N/A
11/24/2020	Oppenheimer	Initiated Coverage	Market Perform		Low
11/6/2020	BMO Capital Markets	Lower Price Target	Market Perform	$13.00 ➝ $11.00	High
10/23/2020	Raymond James	Reiterated Rating	Buy		Low
10/13/2020	Argus	Lower Price Target	Average ➝ Buy	$14.00 ➝ $11.00	Low
9/14/2020	Raymond James	Reiterated Rating	Buy		Low
8/26/2020	Bank of America	Reiterated Rating	Sell	$8.00	Low
8/6/2020	SVB Leerink	Boost Price Target	Market Perform	$13.00 ➝ $14.00	Medium
8/6/2020	Barclays	Upgrade	Underweight ➝ Equal Weight	$10.00 ➝ $13.00	Medium
7/27/2020	The Goldman Sachs Group	Initiated Coverage	Neutral	$12.00	Low
6/1/2020	SunTrust Banks	Upgrade	Hold ➝ Buy	$11.00 ➝ $16.00	High
5/11/2020	UBS Group	Boost Price Target	Buy	$12.00 ➝ $15.00	Medium
5/8/2020	Cantor Fitzgerald	Reiterated Rating	Neutral		Low
5/8/2020	SVB Leerink	Boost Price Target	Market Perform	$11.00 ➝ $12.00	Low
5/8/2020	Bank of America	Reiterated Rating	Underperform	$7.00 ➝ $8.00	Low
4/24/2020	Citigroup	Initiated Coverage	Neutral		Low
4/17/2020	Barclays	Reiterated Rating	Sell	$9.00	Low
4/15/2020	Piper Sandler	Lower Price Target	Neutral	$10.00 ➝ $8.00	Low
4/6/2020	UBS Group	Upgrade	Neutral ➝ Buy	$14.00 ➝ $12.00	High
4/2/2020	Morgan Stanley	Lower Price Target	Underweight	$13.00 ➝ $8.00	Medium
3/23/2020	Bank of America	Lower Price Target	Underperform	$11.00 ➝ $7.00	Low
3/5/2020	Wells Fargo & Company	Boost Price Target	Equal Weight	$10.00 ➝ $12.00	Low
2/24/2020	Edward Jones	Downgrade	Hold ➝ Sell		High
2/18/2020	Argus	Boost Price Target	Buy	$10.00 ➝ $15.00	Low
2/17/2020	UBS Group	Boost Price Target	Neutral	$8.00 ➝ $14.00	Medium
2/14/2020	Morgan Stanley	Boost Price Target	Underweight	$8.00 ➝ $13.00	High
2/13/2020	Bank of America	Boost Price Target	Underperform	$8.00 ➝ $11.00	High
2/13/2020	SunTrust Banks	Boost Price Target	Hold	$9.00 ➝ $13.00	Medium
2/13/2020	Oppenheimer	Boost Price Target	Outperform	$12.00 ➝ $16.00	High
2/12/2020	Cantor Fitzgerald	Boost Price Target	In-Line ➝ Neutral	$9.00 ➝ $15.00	Low
2/12/2020	Cfra	Boost Price Target	Hold	$11.00 ➝ $13.00	Low
1/22/2020	Wells Fargo & Company	Boost Price Target	Equal Weight	$8.00 ➝ $10.00	Medium
1/3/2020	Bank of America	Upgrade	Underperform ➝ Buy		High
11/12/2019	JPMorgan Chase & Co.	Upgrade	Underweight ➝ Neutral	$8.00	Medium
10/16/2019	Gabelli	Upgrade	Hold ➝ Buy		High
9/30/2019	Wells Fargo & Company	Lower Price Target	Market Perform	$17.00 ➝ $8.00	Low
9/12/2019	Guggenheim	Initiated Coverage	Neutral		Low
9/6/2019	JPMorgan Chase & Co.	Lower Price Target	Underweight	$9.00 ➝ $7.00	Low
8/16/2019	UBS Group	Set Price Target	Hold	$8.00	High
8/9/2019	BMO Capital Markets	Lower Price Target	Market Perform	$11.00 ➝ $9.00	N/A
8/8/2019	Royal Bank of Canada	Reiterated Rating	Hold	$10.00	High
8/8/2019	SunTrust Banks	Lower Price Target	Hold	$7.00	Medium
8/8/2019	Raymond James	Lower Price Target	Outperform	$22.00 ➝ $15.00	Medium
8/7/2019	Cowen	Set Price Target	Hold	$9.00	Low
7/19/2019	Wolfe Research	Initiated Coverage	Peer Perform ➝ Peer Perform	$9.00	Low
7/15/2019	Morgan Stanley	Downgrade	Equal Weight ➝ Underweight	$16.00 ➝ $6.00	High
7/10/2019	Credit Suisse Group	Reiterated Rating	Neutral		Low
7/5/2019	Argus	Upgrade	Hold ➝ Buy	$12.00	High
6/18/2019	Sanford C. Bernstein	Lower Price Target	Market Perform	$17.00 ➝ $11.00	Medium
6/17/2019	Mizuho	Set Price Target	Hold	$11.00	Medium
6/17/2019	Citigroup	Set Price Target	Buy	$23.00 ➝ $13.00	Low
6/12/2019	Oppenheimer	Set Price Target	Buy	$12.00	High
6/12/2019	Cantor Fitzgerald	Lower Price Target	Neutral	$16.00 ➝ $9.00	Low
6/11/2019	Barclays	Initiated Coverage	Underweight ➝ Underweight	$8.00	Medium
6/3/2019	CIBC	Upgrade	Market Perform ➝ Outperform	$12.00	Medium
6/3/2019	Oppenheimer	Upgrade	Market Perform ➝ Outperform	$12.00	Low
5/30/2019	Bank of America	Downgrade	Buy ➝ Underperform	$19.00 ➝ $9.00	High
5/28/2019	Wells Fargo & Company	Set Price Target	Hold	$17.00	Medium
5/28/2019	UBS Group	Downgrade	Buy ➝ Neutral	$22.00 ➝ $12.00	High
5/10/2019	Wells Fargo & Company	Reiterated Rating	Hold		High
5/9/2019	Wells Fargo & Company	Lower Price Target	Market Perform	$18.00 ➝ $17.00	Low
5/3/2019	Royal Bank of Canada	Set Price Target	Hold	$19.00	Low
5/3/2019	BMO Capital Markets	Set Price Target	Hold	$17.00	Low
5/3/2019	Morgan Stanley	Set Price Target	Hold	$16.00	Low
5/3/2019	Cantor Fitzgerald	Boost Price Target	Positive ➝ Neutral	$16.00 ➝ $25.00	Medium
5/2/2019	Maxim Group	Reiterated Rating	Hold		Low
4/11/2019	Citigroup	Lower Price Target	Buy	$27.00 ➝ $23.00	Low
4/3/2019	Wells Fargo & Company	Lower Price Target	Market Perform ➝ Market Perform	$20.00 ➝ $18.00	Low
3/28/2019	BMO Capital Markets	Initiated Coverage	Market Perform	$18.00	Medium
3/19/2019	SunTrust Banks	Initiated Coverage	Hold ➝ Hold	$17.00	Low
3/7/2019	UBS Group	Initiated Coverage	Buy	$22.00	Medium
3/6/2019	Morgan Stanley	Downgrade	Overweight ➝ Equal Weight	$17.00	High
2/20/2019	Mizuho	Downgrade	Buy ➝ Neutral	$25.00 ➝ $18.00	Medium
2/14/2019	Credit Suisse Group	Lower Price Target	Neutral ➝ Neutral	$26.00 ➝ $20.00	Medium
2/14/2019	Raymond James	Upgrade	Market Perform ➝ Outperform	$22.00	Medium
2/14/2019	Maxim Group	Reiterated Rating	Hold		Medium
2/14/2019	Wells Fargo & Company	Reiterated Rating	Hold	$24.00 ➝ $20.00	Medium
2/11/2019	Oppenheimer	Reiterated Rating	Hold		Medium
2/5/2019	Credit Suisse Group	Reiterated Rating	Hold	$26.00	High
2/5/2019	HSBC	Set Price Target	Sell	$12.00	High
2/5/2019	Bank of America	Reiterated Rating	Buy	$24.00	Low
1/23/2019	Piper Jaffray Companies	Upgrade	Underweight ➝ Neutral	$15.00 ➝ $16.00	Low
1/23/2019	UBS Group	Upgrade	Neutral ➝ Buy		Low
1/3/2019	Bank of America	Upgrade	Underperform ➝ Buy	$16.12	High
12/13/2018	Credit Suisse Group	Set Price Target	Hold	$26.00	Medium
11/7/2018	Oppenheimer	Reiterated Rating	Hold		Medium
11/5/2018	Morgan Stanley	Upgrade	Equal Weight ➝ Overweight	$20.00 ➝ $27.00	Low
11/2/2018	Bank of America	Boost Price Target	Underperform ➝ Underperform	$19.00 ➝ $20.00	Low
11/2/2018	Royal Bank of Canada	Set Price Target	Hold	$22.00	Low
11/2/2018	Wells Fargo & Company	Reiterated Rating	Hold		Low
11/1/2018	Maxim Group	Reiterated Rating	Hold		High
11/1/2018	Oppenheimer	Reiterated Rating	Hold		High
10/17/2018	Wells Fargo & Company	Set Price Target	Hold	$23.00	Low
10/17/2018	Oppenheimer	Reiterated Rating	Hold		Medium
10/14/2018	Credit Suisse Group	Set Price Target	Hold	$26.00	Medium
10/1/2018	The Goldman Sachs Group	Upgrade	Buy ➝ Conviction-Buy	$30.00	High
10/1/2018	SVB Leerink	Upgrade	Underperform ➝ Market Perform	$16.00 ➝ $24.00	High
9/27/2018	Wells Fargo & Company	Set Price Target	Hold	$23.00	Low
9/27/2018	Cantor Fitzgerald	Reiterated Rating	Hold	$25.00	High
9/21/2018	CIBC	Reiterated Rating	Market Perform ➝ Market Perform		Low
9/20/2018	Oppenheimer	Reiterated Rating	Hold		Medium
9/17/2018	Mizuho	Boost Price Target	Buy	$28.00 ➝ $29.00	High
9/17/2018	Credit Suisse Group	Set Price Target	Hold	$23.00 ➝ $26.00	High
9/17/2018	Wells Fargo & Company	Set Price Target	Hold	$23.00	High
9/17/2018	BTIG Research	Upgrade	Sell ➝ Neutral		High
9/14/2018	Cantor Fitzgerald	Set Price Target	Hold	$25.00	Low
9/7/2018	Credit Suisse Group	Downgrade	Outperform ➝ Neutral	$25.00 ➝ $23.00	Low
8/24/2018	Mizuho	Reiterated Rating	Buy	$28.00	Low
8/16/2018	Mizuho	Reiterated Rating	Buy	$28.00	High
8/16/2018	Cantor Fitzgerald	Reiterated Rating	Hold	$25.00	High
8/3/2018	Morgan Stanley	Boost Price Target	Equal Weight ➝ Equal Weight	$19.00 ➝ $20.00	Medium
8/3/2018	Jefferies Financial Group	Reiterated Rating	Hold	$21.00	Medium
8/2/2018	Barclays	Set Price Target	Equal Weight ➝ Hold	$20.00 ➝ $23.00	Medium
8/2/2018	Cantor Fitzgerald	Set Price Target	Hold	$25.00	Medium
8/2/2018	Oppenheimer	Reiterated Rating	Hold		Medium
8/2/2018	Mizuho	Reiterated Rating	Buy	$27.00	High
8/2/2018	Wells Fargo & Company	Set Price Target	Hold	$23.00	Medium
7/31/2018	Royal Bank of Canada	Reiterated Rating	Hold	$19.00	Medium
7/19/2018	Cantor Fitzgerald	Set Price Target	Hold	$25.00	Medium
7/13/2018	Cantor Fitzgerald	Set Price Target	Neutral ➝ Hold	$18.00 ➝ $25.00	Low
6/27/2018	Citigroup	Boost Price Target	Buy	$25.00 ➝ $27.00	Medium
6/25/2018	The Goldman Sachs Group	Boost Price Target	Buy	$25.00 ➝ $28.00	Medium
6/18/2018	Wells Fargo & Company	Upgrade	Underperform ➝ Market Perform		Medium
5/31/2018	Citigroup	Set Price Target	Buy ➝ Buy	$24.00 ➝ $25.00	Low
5/24/2018	Barclays	Set Price Target	Equal Weight ➝ Hold	$13.00 ➝ $20.00	Medium
5/17/2018	Cantor Fitzgerald	Set Price Target	Hold	$18.00	Low
5/14/2018	Credit Suisse Group	Set Price Target	Buy	$23.00	Low
5/7/2018	Oppenheimer	Reiterated Rating	Hold		Low
5/7/2018	Morgan Stanley	Reiterated Rating	Equal Weight ➝ Hold	$18.00	Low
5/3/2018	Cantor Fitzgerald	Set Price Target	Hold	$18.00	Low
5/3/2018	Maxim Group	Reiterated Rating	Hold		Low
4/22/2018	Wells Fargo & Company	Set Price Target	Sell	$17.00	Low
4/20/2018	Mizuho	Reiterated Rating	Buy	$27.00	Low
4/4/2018	Credit Suisse Group	Set Price Target	Buy	$23.00	High
3/26/2018	Royal Bank of Canada	Reiterated Rating	Hold	$16.00	Low
3/20/2018	Jefferies Financial Group	Initiated Coverage	Hold ➝ Hold	$19.00	Medium
3/1/2018	Maxim Group	Reiterated Rating	Hold		Medium
2/13/2018	Wells Fargo & Company	Reiterated Rating	Sell		Medium
2/11/2018	Credit Suisse Group	Upgrade	Neutral ➝ Outperform	$20.00 ➝ $23.00	Medium
2/9/2018	Bank of America	Lower Price Target	Underperform ➝ Underperform	$17.00 ➝ $16.00	Low
2/9/2018	SVB Leerink	Lower Price Target	Underweight ➝ Underperform	$17.00 ➝ $16.00	High
2/9/2018	Deutsche Bank Aktiengesellschaft	Lower Price Target	Hold ➝ Hold	$20.00 ➝ $18.00	Medium
2/9/2018	Gabelli	Downgrade	Buy ➝ Hold	$19.00	Medium
2/9/2018	Piper Jaffray Companies	Downgrade	Neutral ➝ Underweight	$11.00	Medium
2/9/2018	Royal Bank of Canada	Upgrade	Underperform ➝ Sector Perform	$18.00	Medium
2/8/2018	Cantor Fitzgerald	Set Price Target	Hold	$18.00	Medium
2/8/2018	Oppenheimer	Reiterated Rating	Hold		Medium
2/8/2018	Maxim Group	Reiterated Rating	Hold		Medium
2/2/2018	BTIG Research	Downgrade	Neutral ➝ Sell	$17.00	Low
1/30/2018	Royal Bank of Canada	Set Price Target	Sell	$13.00	Low
1/26/2018	SVB Leerink	Boost Price Target	Underperform	$15.00 ➝ $17.00	Low
1/25/2018	Susquehanna Bancshares	Reiterated Rating	Positive ➝ Positive	$22.00 ➝ $24.00	Medium
1/24/2018	Royal Bank of Canada	Set Price Target	Sell	$13.00	Low
1/23/2018	Oppenheimer	Reiterated Rating	Hold		Low
1/22/2018	Credit Suisse Group	Set Price Target	Hold	$20.00	Low
1/22/2018	Maxim Group	Reiterated Rating	Hold		Low
1/22/2018	Wells Fargo & Company	Reiterated Rating	Sell		Low
1/18/2018	BTIG Research	Downgrade	Buy ➝ Neutral	$24.00	Low
1/11/2018	The Goldman Sachs Group	Boost Price Target	Buy	$20.00 ➝ $25.00	High
1/9/2018	Mizuho	Upgrade	Neutral ➝ Buy	$19.12 ➝ $23.00	N/A
1/5/2018	Wells Fargo & Company	Downgrade	Market Perform ➝ Underperform	$19.58 ➝ $17.00	Low
1/4/2018	Citigroup	Upgrade	Neutral ➝ Buy	$24.00	Low
1/3/2018	Cantor Fitzgerald	Set Price Target	Hold	$18.00	Medium
1/2/2018	SVB Leerink	Initiated Coverage	Underperform ➝ Underperform	$15.00	Medium
12/28/2017	Cantor Fitzgerald	Set Price Target	Hold	$18.00	Low
12/18/2017	UBS Group	Set Price Target	Hold	$12.00 ➝ $20.00	Low
12/15/2017	Royal Bank of Canada	Set Price Target	Sell	$13.00	Low
12/15/2017	Deutsche Bank Aktiengesellschaft	Set Price Target	Hold	$20.00	Medium
12/15/2017	Credit Suisse Group	Upgrade	Underperform ➝ Neutral	$8.00 ➝ $20.00	Medium
12/15/2017	Morgan Stanley	Upgrade	Underweight ➝ Equal Weight	$18.00	Medium
12/15/2017	BTIG Research	Boost Price Target		$20.00	High
12/15/2017	The Goldman Sachs Group	Upgrade	Neutral ➝ Buy	$20.00	High
12/14/2017	Wells Fargo & Company	Reiterated Rating	Hold		High
12/14/2017	Piper Jaffray Companies	Set Price Target	Hold	$16.00	High
12/14/2017	Oppenheimer	Reiterated Rating	Hold		High
12/14/2017	Cantor Fitzgerald	Set Price Target	Hold	$10.00	High
12/12/2017	Guggenheim	Initiated Coverage	Neutral ➝ Neutral	$16.00	High
11/29/2017	Royal Bank of Canada	Set Price Target	Sell	$11.00	Low
11/29/2017	Mizuho	Boost Price Target	Neutral ➝ Neutral	$12.00 ➝ $16.00	Medium
11/28/2017	BTIG Research	Set Price Target	Buy	$16.00	Low
11/27/2017	Cantor Fitzgerald	Set Price Target	Hold	$10.00	High
11/25/2017	Wells Fargo & Company	Reiterated Rating	Hold		High
11/17/2017	Mizuho	Reiterated Rating	Neutral ➝ Neutral	$15.00 ➝ $12.00	N/A
11/14/2017	Cantor Fitzgerald	Set Price Target	Hold	$10.00	N/A
11/13/2017	JPMorgan Chase & Co.	Downgrade	Neutral ➝ Underweight	$11.48 ➝ $11.00	N/A
11/12/2017	Oppenheimer	Reiterated Rating	Hold		N/A
11/6/2017	Susquehanna Bancshares	Lower Price Target	Positive ➝ Positive	$20.00 ➝ $14.00	N/A
11/6/2017	Credit Suisse Group	Reiterated Rating	Underperform	$14.00 ➝ $8.00	N/A
11/5/2017	Royal Bank of Canada	Boost Price Target	Underperform	$8.00 ➝ $13.00	N/A
11/3/2017	Piper Jaffray Companies	Reiterated Rating	Hold	$12.00	N/A
11/3/2017	Morgan Stanley	Lower Price Target	Underweight	$14.00 ➝ $7.00	N/A
11/3/2017	Deutsche Bank Aktiengesellschaft	Downgrade	Buy ➝ Hold	$14.00	N/A
11/2/2017	Wells Fargo & Company	Downgrade	Market Perform	$17.00 ➝ $11.36	N/A
10/30/2017	Mizuho	Reiterated Rating	Hold	$15.00	N/A
10/30/2017	Royal Bank of Canada	Reiterated Rating	Underperform ➝ Underperform	$15.00 ➝ $13.00	N/A
10/26/2017	Cantor Fitzgerald	Set Price Target	Hold	$17.00	N/A
10/25/2017	Evercore ISI	Set Price Target	Buy	$38.00	N/A
10/20/2017	Royal Bank of Canada	Set Price Target	Sell	$15.00	N/A
10/20/2017	Barclays	Set Price Target	Hold	$21.00 ➝ $19.00	N/A
10/19/2017	Cantor Fitzgerald	Set Price Target	Hold	$17.00	N/A
10/6/2017	Piper Jaffray Companies	Set Price Target	Hold	$23.00	N/A
10/5/2017	Morgan Stanley	Set Price Target	Underweight	$16.00 ➝ $15.00	N/A
10/5/2017	Wells Fargo & Company	Reiterated Rating	Market Perform		N/A
10/4/2017	Wells Fargo & Company	Set Price Target	Hold	$20.00	N/A
10/4/2017	Cowen	Reiterated Rating	Market Perform	$30.00 ➝ $18.00	N/A
10/4/2017	Maxim Group	Reiterated Rating	Hold		N/A
10/4/2017	Oppenheimer	Reiterated Rating	Hold		Medium
10/4/2017	Mizuho	Reiterated Rating	Hold	$16.00	Medium
10/4/2017	Barclays	Set Price Target	Equal Weight	$23.00 ➝ $21.00	Medium
10/4/2017	BTIG Research	Reiterated Rating	Buy	$24.00	Medium
10/2/2017	Cantor Fitzgerald	Set Price Target	Hold	$17.00	Low
9/21/2017	Sanford C. Bernstein	Lower Price Target	Mkt Perform ➝ Market Perform	$28.00 ➝ $20.00	Low
9/18/2017	Cantor Fitzgerald	Reiterated Rating	Hold	$17.00	Low
9/18/2017	Royal Bank of Canada	Lower Price Target	Underperform	$21.00 ➝ $15.00	High
9/14/2017	Maxim Group	Reiterated Rating	Hold	$15.50	Low
9/14/2017	UBS Group	Reiterated Rating	Neutral	$19.00	Low
9/13/2017	Gabelli	Reiterated Rating	Buy		Low
9/12/2017	Jefferies Financial Group	Lower Price Target	Hold	$21.00 ➝ $18.50	High
9/11/2017	Oppenheimer	Reiterated Rating	Hold		Low
9/11/2017	Cantor Fitzgerald	Set Price Target	Hold	$27.00 ➝ $17.00	High
9/11/2017	BTIG Research	Upgrade	Neutral ➝ Buy	$24.00	High
9/6/2017	JMP Securities	Boost Price Target	Underperform	$13.00 ➝ $14.00	Low
9/5/2017	Royal Bank of Canada	Reiterated Rating	Underperform		Medium
9/5/2017	Cantor Fitzgerald	Reiterated Rating	Neutral	$27.00	High
8/31/2017	The Goldman Sachs Group	Reiterated Rating	Neutral	$28.00 ➝ $21.00	Low
8/30/2017	Cantor Fitzgerald	Reiterated Rating	Hold	$27.00	Low
8/23/2017	Credit Suisse Group	Downgrade	Neutral ➝ Underperform	$25.00 ➝ $13.00	Medium
8/22/2017	Mizuho	Reiterated Rating	Neutral	$30.00 ➝ $16.00	Low
8/16/2017	Citigroup	Downgrade	Buy ➝ Neutral	$32.00 ➝ $19.00	Medium
8/9/2017	Deutsche Bank Aktiengesellschaft	Reiterated Rating	Buy	$43.00 ➝ $28.00	High
8/9/2017	Jefferies Financial Group	Reiterated Rating	Hold	$33.00 ➝ $26.00	Medium
8/9/2017	Cantor Fitzgerald	Reiterated Rating	Neutral	$31.00 ➝ $27.00	High
8/9/2017	Credit Suisse Group	Reiterated Rating	Outperform	$39.00	High
8/7/2017	Barclays	Lower Price Target	Equal Weight	$38.00 ➝ $23.00	High
8/4/2017	Piper Jaffray Companies	Reiterated Rating	Neutral	$28.00 ➝ $23.00	High
8/4/2017	Sanford C. Bernstein	Downgrade	Outperform ➝ Market Perform	$42.00 ➝ $28.00	High
8/4/2017	Maxim Group	Reiterated Rating	Hold	$35.00	High
8/4/2017	Cowen	Downgrade	Outperform ➝ Market Perform	$50.00 ➝ $30.00	High
8/4/2017	Credit Suisse Group	Downgrade	Outperform ➝ Neutral	$39.00 ➝ $25.00	High
8/4/2017	Royal Bank of Canada	Downgrade	Outperform ➝ Underperform	$37.00 ➝ $21.00	N/A
8/3/2017	Cantor Fitzgerald	Set Price Target	Hold	$27.00	High
8/3/2017	CIBC	Reiterated Rating	Outperform ➝ Market Perform		High
8/3/2017	UBS Group	Downgrade	Outperform ➝ Market Perform		High
8/3/2017	Credit Suisse Group	Set Price Target	Buy	$39.00	High
8/3/2017	Oppenheimer	Downgrade	Outperform ➝ Market Perform	$41.00	High
8/2/2017	Mizuho	Reiterated Rating	Hold	$30.00	High
7/25/2017	Jefferies Financial Group	Reiterated Rating	Neutral ➝ Hold		Low
7/18/2017	Oppenheimer	Reiterated Rating	Outperform	$41.00	Low
7/17/2017	Royal Bank of Canada	Reiterated Rating	Outperform ➝ Outperform	$38.00 ➝ $37.00	Low
7/13/2017	Maxim Group	Reiterated Rating	Hold	$35.00	High
6/27/2017	Oppenheimer	Set Price Target	Buy	$41.00	Low
6/27/2017	Wells Fargo & Company	Reiterated Rating	Hold		N/A
6/23/2017	Jefferies Financial Group	Reiterated Rating	Hold	$33.00	Low
6/22/2017	Cantor Fitzgerald	Set Price Target	Hold	$31.00	Low
6/16/2017	Royal Bank of Canada	Set Price Target	Buy	$38.00	Low
6/15/2017	Cantor Fitzgerald	Initiated Coverage	Neutral ➝ Neutral	$31.00	Low
6/15/2017	Mizuho	Upgrade	Neutral ➝ Buy	$25.00 ➝ $30.00	Low
5/31/2017	Oppenheimer	Reiterated Rating	Buy		Low
5/17/2017	Credit Suisse Group	Reiterated Rating	Buy	$39.00	High
5/15/2017	Royal Bank of Canada	Reiterated Rating	Outperform	$42.00 ➝ $38.00	Low
5/12/2017	Deutsche Bank Aktiengesellschaft	Lower Price Target	Buy	$45.00 ➝ $43.00	Low
5/11/2017	Maxim Group	Set Price Target	Hold	$35.00	Low
4/29/2017	Wells Fargo & Company	Reiterated Rating	Market Perform		Low
4/25/2017	Citigroup	Lower Price Target	Buy	$47.00 ➝ $42.00	High
4/7/2017	CIBC	Reiterated Rating	Buy	$43.00	Low
4/6/2017	Oppenheimer	Set Price Target	Buy	$43.00	Low
4/6/2017	BTIG Research	Reiterated Rating	Neutral		Low
4/4/2017	Cowen	Reiterated Rating	Outperform	$50.00	Low
3/29/2017	Maxim Group	Reiterated Rating	Outperform	$35.00	Low
3/16/2017	Jefferies Financial Group	Set Price Target	Hold	$33.00	Low
2/28/2017	Argus	Downgrade	Buy ➝ Hold	$59.35 ➝ $31.90	N/A
2/24/2017	Sanford C. Bernstein	Reiterated Rating	Outperform	$42.00	N/A
2/21/2017	Royal Bank of Canada	Reiterated Rating	Sector Perform	$42.00	N/A
2/17/2017	JPMorgan Chase & Co.	Set Price Target	Hold	$37.00	N/A
2/16/2017	BTIG Research	Reiterated Rating	Neutral	$34.00	N/A
2/14/2017	Wells Fargo & Company	Reiterated Rating	Hold		N/A
2/14/2017	Oppenheimer	Set Price Target	Buy	$43.00	N/A
2/14/2017	Jefferies Financial Group	Set Price Target	Hold	$36.00 ➝ $33.00	N/A
2/14/2017	Royal Bank of Canada	Reiterated Rating	Outperform	$42.00	N/A
2/13/2017	Maxim Group	Lower Price Target	Hold	$41.00 ➝ $40.00	N/A
2/10/2017	Mizuho	Downgrade	Buy ➝ Underperform	$40.00 ➝ $27.00	N/A
2/7/2017	Sanford C. Bernstein	Set Price Target	Buy	$42.00	N/A
2/7/2017	Mizuho	Reiterated Rating	Buy ➝ Neutral	$40.00 ➝ $27.00	N/A
2/7/2017	Citigroup	Reiterated Rating	Buy	$47.00	N/A
2/1/2017	Maxim Group	Set Price Target	Hold	$41.00	N/A
2/1/2017	Oppenheimer	Reiterated Rating	Outperform		N/A
1/31/2017	Deutsche Bank Aktiengesellschaft	Reiterated Rating	Buy	$48.00	N/A
1/31/2017	Barclays	Lower Price Target	Equal Weight	$46.00 ➝ $38.00	N/A
1/31/2017	Bank of America	Upgrade	Neutral ➝ Buy		N/A
1/20/2017	JPMorgan Chase & Co.	Downgrade	Overweight ➝ Neutral		N/A
1/10/2017	Cowen	Reiterated Rating	Buy	$100.00 ➝ $50.00	N/A
1/9/2017	Royal Bank of Canada	Set Price Target	Buy	$51.00 ➝ $42.00	N/A
1/9/2017	Jefferies Financial Group	Reiterated Rating	Hold	$36.00	N/A
1/9/2017	Gabelli	Reiterated Rating	Buy		N/A
1/9/2017	Wells Fargo & Company	Downgrade	Outperform ➝ Market Perform	$52.00 ➝ $38.00	N/A
1/6/2017	Maxim Group	Downgrade	Buy ➝ Hold	$49.00 ➝ $41.00	N/A
1/3/2017	Maxim Group	Lower Price Target	Buy	$52.00 ➝ $49.00	N/A
12/28/2016	Credit Suisse Group	Reiterated Rating	Outperform	$47.00	N/A
12/28/2016	Barclays	Reiterated Rating	Equal Weight	$46.00	N/A
12/23/2016	Guggenheim	Reiterated Rating	Buy	$80.00	N/A
12/7/2016	Oppenheimer	Reiterated Rating	Outperform		N/A
12/7/2016	Deutsche Bank Aktiengesellschaft	Reiterated Rating	Buy	$54.00	N/A
12/7/2016	Sanford C. Bernstein	Reiterated Rating	Outperform	$52.00	N/A
12/6/2016	Oppenheimer	Set Price Target	Buy	$66.00 ➝ $50.00	N/A
12/4/2016	Maxim Group	Reiterated Rating	Buy	$72.00 ➝ $52.00	N/A
12/4/2016	Morgan Stanley	Downgrade	Overweight ➝ Equal Weight	$63.00 ➝ $42.00	N/A
12/4/2016	BTIG Research	Downgrade	Buy ➝ Neutral		N/A
12/4/2016	Jefferies Financial Group	Downgrade	Buy ➝ Hold	$69.00 ➝ $40.00	N/A
11/30/2016	Barclays	Reiterated Rating	Equal Weight	$46.00	N/A
11/30/2016	Royal Bank of Canada	Reiterated Rating	Outperform	$71.00 ➝ $58.00	N/A
11/18/2016	Guggenheim	Reiterated Rating	Buy	$80.00	N/A
11/16/2016	Deutsche Bank Aktiengesellschaft	Lower Price Target	Buy	$68.00 ➝ $54.00	N/A
11/16/2016	Maxim Group	Reiterated Rating	Buy	$72.00 ➝ $52.00	N/A
11/16/2016	Royal Bank of Canada	Lower Price Target	Outperform	$58.00 ➝ $51.00	N/A
11/16/2016	BTIG Research	Downgrade	Buy ➝ Neutral		N/A
11/16/2016	Jefferies Financial Group	Downgrade	Buy ➝ Hold	$69.00 ➝ $40.00	N/A
11/16/2016	Mizuho	Lower Price Target	Neutral	$45.00 ➝ $40.00	N/A
11/16/2016	Morgan Stanley	Downgrade	Overweight ➝ Equal Weight	$63.00 ➝ $42.00	N/A
11/14/2016	Royal Bank of Canada	Set Price Target	Buy	$71.00 ➝ $58.00	N/A
11/14/2016	Royal Bank of Canada	Lower Price Target	Outperform	$71.00 ➝ $58.00	N/A
11/14/2016	Barclays	Initiated Coverage	Equal Weight	$46.00	N/A
11/7/2016	Bank of America	Downgrade	Buy ➝ Neutral	$48.00	N/A
10/31/2016	Credit Suisse Group	Upgrade	Neutral ➝ Outperform	$59.00 ➝ $52.00	N/A
10/24/2016	Mizuho	Downgrade	Buy ➝ Neutral	$64.00 ➝ $45.00	N/A
10/15/2016	Deutsche Bank Aktiengesellschaft	Set Price Target	Buy	$68.00	N/A
10/14/2016	Maxim Group	Set Price Target	Buy	$72.00	N/A
10/7/2016	SVB Leerink	Set Price Target	Buy	$57.00	N/A
10/5/2016	Guggenheim	Reiterated Rating	Buy	$80.00	N/A
10/3/2016	Wells Fargo & Company	Reiterated Rating	Buy		N/A
10/1/2016	Bank of America	Set Price Target	Buy	$72.00	N/A
9/29/2016	OTR Global	Initiated Coverage	Positive		N/A
9/26/2016	Mizuho	Reiterated Rating	Buy	$64.00	N/A
9/23/2016	SVB Leerink	Reiterated Rating	Buy		N/A
9/12/2016	Oppenheimer	Set Price Target	Buy	$66.00	N/A
9/12/2016	Jefferies Financial Group	Set Price Target	Buy	$69.00	N/A
9/12/2016	Morgan Stanley	Set Price Target	Buy	$63.00	N/A
9/11/2016	Royal Bank of Canada	Set Price Target	Buy	$71.00	N/A
9/2/2016	Oppenheimer	Upgrade	Market Perform ➝ Outperform	$66.00	N/A
8/31/2016	SVB Leerink	Set Price Target	Outperform	$66.00 ➝ $61.00	N/A
8/25/2016	Mizuho	Reiterated Rating	Buy	$70.00 ➝ $64.00	N/A
8/25/2016	Credit Suisse Group	Reiterated Rating	Neutral	$59.00 ➝ $51.63	N/A
8/16/2016	SVB Leerink	Reiterated Rating	Outperform	$66.00	N/A
8/15/2016	Guggenheim	Reiterated Rating	Buy	$80.00	N/A
8/8/2016	Piper Jaffray Companies	Reiterated Rating	Neutral	$55.00 ➝ $57.00	N/A
8/5/2016	Oppenheimer	Downgrade	Outperform ➝ Market Perform	$70.29	N/A
8/5/2016	Mizuho	Reiterated Rating	Buy	$75.00 ➝ $70.00	N/A
8/3/2016	Jefferies Financial Group	Reiterated Rating	Buy		N/A
8/1/2016	Credit Suisse Group	Reiterated Rating	Neutral		N/A
7/26/2016	JPMorgan Chase & Co.	Reiterated Rating	Overweight	$75.00	N/A
7/25/2016	Mizuho	Reiterated Rating	Buy		N/A
7/20/2016	Royal Bank of Canada	Reiterated Rating	Outperform	$71.00	N/A
7/18/2016	Maxim Group	Reiterated Rating	Buy		N/A
7/18/2016	Royal Bank of Canada	Reiterated Rating	Buy		N/A
7/17/2016	Mizuho	Reiterated Rating	Buy		N/A
7/17/2016	The Goldman Sachs Group	Lower Price Target		$70.00 ➝ $60.00	N/A
7/15/2016	Piper Jaffray Companies	Reiterated Rating	Neutral	$58.00 ➝ $53.00	N/A
7/15/2016	The Goldman Sachs Group	Downgrade	Buy ➝ Neutral	$70.00 ➝ $60.00	N/A
7/14/2016	Oppenheimer	Lower Price Target	Outperform	$77.00 ➝ $72.00	N/A
7/14/2016	Jefferies Financial Group	Lower Price Target	Buy	$72.00 ➝ $69.00	N/A
7/12/2016	Royal Bank of Canada	Lower Price Target	Outperform	$75.00 ➝ $71.00	N/A
6/25/2016	JPMorgan Chase & Co.	Reiterated Rating	Overweight		N/A

(Data available from 6/21/2016 forward)

Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage forms, including tablets, capsules, injectables, inhalants, liquids, ointments, and creams. It also develops, manufactures, and sells active pharmaceutical ingredients. In addition, it focuses on the central nervous system, pain, respiratory, and oncology areas. Its products in the central nervous system and pain area include Copaxone for the treatment of relapsing forms of multiple sclerosis; AJOVY for the preventive treatment of migraine; and AUSTEDO for the treatment of tardive dyskinesia and chorea associated with Huntington disease. The company's products in the respiratory market comprise ProAir, QVAR, ProAir Digihaler, AirDuo Digihaler, and ArmonAir Digihaler, BRALTUS, CINQAIR/CINQAERO, DuoResp Spiromax, and AirDuo RespiClick/ArmonAir RespiClick for the treatment of asthma and chronic obstructive pulmonary disease. Its products in the oncology market include Bendeka, Treanda, Granix, Trisenox, Lonquex, and Tevagrastim/Ratiograstim. The company was founded in 1901 and is headquartered in Petach Tikva, Israel.

Today's Range

Now: $10.11

$10.03

$10.20

50 Day Range

MA: $10.56

$10.09

$11.53

52 Week Range

Now: $10.11

$8.44

$13.30

Volume

8,748,794 shs

Average Volume

8,999,384 shs

Market Capitalization

$11.04 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.46

Frequently Asked Questions

What sell-side analysts currently cover shares of Teva Pharmaceutical Industries?

The following sell-side analysts have issued research reports on Teva Pharmaceutical Industries in the last year: Argus, Bank of America Co., Barclays PLC, BMO Capital Markets, JPMorgan Chase & Co., Oppenheimer Holdings Inc., Raymond James, SVB Leerink LLC, The Goldman Sachs Group, Inc., TheStreet, UBS Group AG, and Zacks Investment Research.
View the latest analyst ratings for TEVA.

What is the current price target for Teva Pharmaceutical Industries?

8 Wall Street analysts have set twelve-month price targets for Teva Pharmaceutical Industries in the last year. Their average twelve-month price target is $11.25, suggesting a possible upside of 11.2%. SVB Leerink LLC has the highest price target set, predicting TEVA will reach $14.00 in the next twelve months. Bank of America Co. has the lowest price target set, forecasting a price of $8.00 for Teva Pharmaceutical Industries in the next year.
View the latest price targets for TEVA.

What is the current consensus analyst rating for Teva Pharmaceutical Industries?

Teva Pharmaceutical Industries currently has 1 sell rating, 7 hold ratings and 2 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Hold." A "hold" rating indicates that analysts believe investors should keep any existing positions they have in TEVA, but not buy more shares or sell existing shares.
View the latest ratings for TEVA.

What other companies compete with Teva Pharmaceutical Industries?

Other companies that are similar to Teva Pharmaceutical Industries include Alexion Pharmaceuticals, Astellas Pharma, BeiGene, Shiseido, Genmab A/S, Royalty Pharma, Genmab A/S, Takeda Pharmaceutical, MERCK Kommanditgesellschaft auf Aktien, Horizon Therapeutics Public, Alnylam Pharmaceuticals, Catalent, UCB, Viatris and Elanco Animal Health.

How do I contact Teva Pharmaceutical Industries' investor relations team?

Teva Pharmaceutical Industries' physical mailing address is 5 BAZEL ST P O B 3190, PETACH TIKVA L3, 49131. The company's listed phone number is 972-3914-8171 and its investor relations email address is [email protected] The official website for Teva Pharmaceutical Industries is www.tevapharm.com.